Published in J Urol on April 01, 1991
Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol (2005) 1.49
The role of invasive and non-invasive urodynamics in male voiding lower urinary tract symptoms. World J Urol (2009) 1.46
Age, gender, and voided volume dependency of peak urinary flow rate and uroflowmetry nomogram in the Indian population. Indian J Urol (2009) 1.38
The effect of a 6 Fr catheter on flow rate in men. Urol Ann (2013) 0.80
Correlation between penile cuff test and pressure-flow study in patients candidates for trans-urethral resection of prostate. BMC Urol (2014) 0.80
Re: Bladder outlet obstruction versus impaired detrusor contractility: the role of uroflow. J Urol (1993) 0.75
The challenges in the diagnosis of detrusor underactivity in clinical practice: A mini-review. Arab J Urol (2016) 0.75
Association Between Overactive Bladder and Polyneuropathy in Diabetic Patients. Int Neurourol J (2016) 0.75
Simple Modification of the Bladder Outlet Obstruction Index for Better Prediction of Endoscopically-Proven Prostatic Obstruction: A Preliminary Study. PLoS One (2015) 0.75
Is multichannel urodynamic assessment necessary before considering a surgical treatment of BPH? Pros and cons. World J Urol (2015) 0.75
A simplified urinary incontinence score for the evaluation of treatment outcomes. Neurourol Urodyn (2000) 5.08
Health care for all. Neurourol Urodyn (1998) 5.04
Keeping score. Neurourol Urodyn (2000) 5.03
Pharmacokinetics of ceftriaxone in humans. Antimicrob Agents Chemother (1981) 3.59
The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl (1988) 3.12
Numbers are better than words. Verbal specifications of frequency have no place in medicine. Am J Med (1983) 2.29
Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol (1992) 2.18
Protracted urinary retention necessitating urethrolysis following tension-free vaginal tape surgery. J Urol (2000) 2.16
Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. J Pharm Sci (1973) 2.01
The effect of genital prolapse on voiding. J Urol (1999) 1.89
Urodynamic findings in patients with diabetic cystopathy. J Urol (1995) 1.88
Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab (1983) 1.84
The role of neuromodulation in the management of urinary urge incontinence. BJU Int (2003) 1.73
The neurophysiology of micturition: a clinical study of 550 patients. J Urol (1982) 1.71
Bladder outlet obstruction in women: definition and characteristics. Neurourol Urodyn (2000) 1.64
The right to effective behavioral treatment. J Appl Behav Anal (1988) 1.62
A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting. Int J Clin Pract (2007) 1.59
Pharmacokinetic profile of ceftriaxone in man. Am J Med (1984) 1.58
Making doctors. Neurourol Urodyn (1999) 1.54
Urodynamics and the etiology of post-prostatectomy urinary incontinence: the initial Columbia experience. J Urol (1995) 1.53
Definition and classification of urinary incontinence: recommendations of the Urodynamic Society. Neurourol Urodyn (1997) 1.52
Suprameatal transvaginal urethrolysis. J Urol (1999) 1.49
Periurethral injection of autologous fat for the treatment of sphincteric incontinence. J Urol (1994) 1.41
Voiding dysfunction in patients with multiple sclerosis. J Enterostomal Ther (1990) 1.40
Defining words: overactive bladder. Neurourol Urodyn (1999) 1.40
Failure to thrive-an analysis of 83 cases. Calif Med (1968) 1.39
"If you build it, they will come". Neurourol Urodyn (1998) 1.39
Transurethral electrovaporization of the prostate. Mayo Clin Proc (1998) 1.38
Blood level profile in man following chronic oral administration of flurazepam hydrochloride. J Pharm Sci (1973) 1.37
Pubovaginal fascial sling for all types of stress urinary incontinence: long-term analysis. J Urol (1998) 1.36
Predicting the need for anti-incontinence surgery in continent women undergoing repair of severe urogenital prolapse. J Urol (2000) 1.32
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. Pharm Res (1998) 1.31
Nocturia. J Urol (2000) 1.31
Urethral diverticulum in women: diverse presentations resulting in diagnostic delay and mismanagement. J Urol (2000) 1.30
The impact of functional analysis methodology on treatment choice for self-injurious and aggressive behavior. J Appl Behav Anal (1999) 1.29
Bladder and sphincter behavior in patients with spinal cord lesions. J Urol (1991) 1.28
Increased incidence of depressive symptoms in men with erectile dysfunction. Urology (1998) 1.27
Noninvasive outcome measures of urinary incontinence and lower urinary tract symptoms: a multicenter study of micturition diary and pad tests. J Urol (2000) 1.24
Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man. J Infect Dis (1973) 1.20
Multiple sclerosis bladder. Studies and care. Ann N Y Acad Sci (1984) 1.19
Increased insulin binding by hepatic plasma membranes from diabetic rats: normalization by insulin therapy. J Clin Invest (1977) 1.19
Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia. J Pediatr (1974) 1.16
Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab (1987) 1.15
Nocturia in adults: etiology and classification. Neurourol Urodyn (1998) 1.13
Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn (1999) 1.12
Nasopharyngeal cancer, sinonasal cancer, and occupations related to formaldehyde: a case-control study. J Natl Cancer Inst (1987) 1.12
Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects. J Pharmacokinet Biopharm (1977) 1.12
Relative usefulness of three growth hormone stimulation screening tests. Am J Dis Child (1979) 1.12
Pharmacokinetic profile of cefixime in man. Pediatr Infect Dis J (1987) 1.11
The bladder is an unreliable witness. Neurourol Urodyn (1996) 1.11
Modification of behavior problems in the home with a parent as observer and experimenter. J Appl Behav Anal (1972) 1.11
Lyme disease presenting as urinary retention. J Urol (1990) 1.11
Pharmacokinetics of flunitrazepam following single- and multiple-dose oral administration to healthy human subjects. J Pharmacokinet Biopharm (1978) 1.10
Bladder neck obstruction in women. J Urol (1987) 1.10
Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron (1987) 1.09
The significance of the American Urological Association symptom index score in the evaluation of women with bladder outlet obstruction. J Urol (2000) 1.09
Detrusor-external sphincter dyssynergia: a detailed electromyographic study. J Urol (1981) 1.08
The pathophysiology of post-radical prostatectomy incontinence: a clinical and video urodynamic study. J Urol (2000) 1.07
Biomarker analysis demonstrates a hypoxic environment in the castrated rat ventral prostate gland. J Cell Biochem (2001) 1.05
Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol (2001) 1.04
Prepubertal gynecomastia caused by an adrenal tumor. Diagnostic value of ultrasonography. Am J Dis Child (1982) 1.04
Echocardiography reveals a high incidence of bicuspid aortic valve in Turner syndrome. J Pediatr (1983) 1.04
Urodynamic findings in Parkinson's disease. J Urol (1987) 1.04
Characteristics of neural injury after abdominoperineal resection. J Urol (1983) 1.04
Eye contact as an antecedent to compliant behavior. J Appl Behav Anal (1984) 1.03
Pharmacokinetic profile of coumermycin A. J Pharm Sci (1970) 1.03
Inguinal hernias in females and the testicular feminization syndrome. Am J Dis Child (1969) 1.00
The bulbocavernosus reflex in urology: a prospective study of 299 patients. J Urol (1981) 1.00
Variation in copy number of a 24-base pair tandem repeat in the chloroplast DNA of Oenothera hookeri strain Johansen. Curr Genet (1988) 0.99
Biopharmaceutical and clinical pharmacokinetic profile of bromazepam. J Pharmacokinet Biopharm (1976) 0.99
Token reinforcement programs in special classes. Except Child (1971) 0.98
Detrusor pressure uroflowmetry studies in women: effect of a 7Fr transurethral catheter. J Urol (2000) 0.98
Standards of efficacy for evaluation of treatment outcomes in urinary incontinence: recommendations of the Urodynamic Society. Neurourol Urodyn (1997) 0.97
Growth without growth hormone: evidence for a potent circulating human growth factor. Lancet (1986) 0.96
Detrusor-external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition. J Urol (1984) 0.96
Pharmacokinetic profile of trimethoprim in dog and man. J Pharm Sci (1970) 0.96
A new approach to electromyography of the external urethral sphincter. J Urol (1977) 0.95
Differential diagnosis of diabetes insipidus: use of DDAVP to terminate the seven-hour water deprivation test. J Pediatr (1981) 0.95
Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function. Pediatr Res (1984) 0.95
Vesicourethral dysfunction in multiple sclerosis. J Urol (1979) 0.95
Behavioral therapy for the treatment of refractory interstitial cystitis. J Urol (1993) 0.94
Inherited abnormal thyroid hormone-binding protein causing selective increase of total serum thyroxine. J Clin Endocrinol Metab (1979) 0.94
Insulin binding and glucose transport in rat skeletal muscle sarcolemmal vesicles. Am J Physiol (1985) 0.94
Denture cleansing: a comparison of two methods. J Prosthet Dent (1984) 0.94
Potential source of error in absorption rate calculations. J Pharmacokinet Biopharm (1975) 0.93
Doxazosin for benign prostatic hyperplasia: long-term efficacy and safety in hypertensive and normotensive patients. The Multicenter Study Group. J Urol (1997) 0.93
Tissue strength analysis of autologous and cadaveric allografts for the pubovaginal sling. Neurourol Urodyn (1999) 0.92
An action of disodium cromoglycate: inhibition of cyclic 3',5'-AMP phosphodiesterase. J Allergy Clin Immunol (1976) 0.92
Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research. Int J Clin Pract (2010) 0.92
Phenacetin metabolism: effect of hydrocarbons and cigarette smoking. Clin Pharmacol Ther (1977) 0.91
Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes. J Pharmacokinet Biopharm (1977) 0.91
Comprehensive laboratory evaluation of impotent men. J Urol (1980) 0.91
Matching training procedures to outcomes. A behavioral and quantitative analysis. Behav Modif (1998) 0.90
Congenital adrenal hypoplasia and hypogonadotropic hypogonadism. Am J Dis Child (1977) 0.90
Idiopathic isosexual precocity. Am J Dis Child (1968) 0.90
Videourodynamic studies in men with lower urinary tract symptoms: a comparison of community based versus referral urological practices. J Urol (2001) 0.90
Transurethral electrovaporization of bladder cancer. Urology (1996) 0.89